Tandem HF Advantages

INCREASED CELL RETENTION AND EFFICACY

 

Tandem™ HF rapidly solves the therapeutic cell retention problem by binding cells, relieving anoikis and when delivered into the heart, anchoring cells in the damaged tissue. Furthermore, Tandem™ HF dampens down the immune system reducing cell loss due to immune rejection.

 

      • First of its kind injectable, human heart cell-derived biomatrix
      • Enables retention, distribution of therapeutic cells
      • Therapeutic cells readily bind and dissociate with biomatrix
      • Favorable biomatrix composition replenishes damaged heart muscle

 

Small-animal studies using relevant pre-clinical models have demonstrated that the properties of Tandem™ HF provide a unique advantage to the use of cell therapies alone.